» Home

» People

  • Norman J. Kachuck, M.D.
  • Leslie P. Weiner, M.D.
  • Margaret Burnett, M.D.
  • Daniel Bandari, M.D.
  • Regina Berkovich, MD, Ph.D
  • Lanelle Cua
  • Patricia Gutierrez
  • M. Linda H. Ignacio
  • José Aparicio
  • Patricia Rourke

» Location

» What We Do

  • Diagnosis and Treatment
  • Management Strategies
  • Research Towards the cure
  • Direct Access To Clinical Trials
  • Center for Innovative Research
  • Physician Education And Consultation

» Clinical Trials

  • Interferon Tau Oral Therapy for Relapsing-Remitting MS
  • Lipitor Trial For Patients with Presumptive MS
  • Anti-IL 12 Monoclonal Antibody Rejection
  • DNA Vaccine Phase I Trial
  • Rituximab (Rituxan ®) Treatment in Peimary Progressive MS
  • Avonex Combined Trial (ACT) for Patients on IFN-BETA-
  • Pregnancy and Immune Function in MS
  • Open Label Follow-Up Trial of Glatiramer Acetate (COPAXONE) in Relapsing Remitting MS
  • Combined AVONEX and NOVANTRONE Therapy Iin MS (CANTIMUS)
  • Sentinel (C-1802) Study
  • 1808 Extension Study

» Questions

» Basic Science

» Useful Links

USC Department of Neurology

USC MS Comprehensive Care Center & Research Group
Healthcare Consultation Center II
1520 San Pablo St., Suite 3000
Los Angeles, CA 90033
Email: mscare@usc.edu

Patient Care
For Appointments, call
323-442-5710
For Clinical Trials, click here

Physicians and Other Professionals
Call: 323-442-5710
FAX: 323-442-5736

© 2004-2005 The MS Comprehensive Care Center at the Keck School of Medicine at USC. All rights reserved.
University of Southern California University of Southern California University of Southern California University of Southern California